BIOXCEL THERAPEUTICS INC (BTAI)
US09075P1057 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -71.00M | -179.05M | -165.76M | -106.93M | -82.17M | |||
| Depreciation Amortization | 310.00K | 318.00K | 330.00K | 300.00K | 190.00K | |||
| Change In Working Capital | -11.37M | 2.31M | 10.67M | 4.98M | 1.02M | |||
| Interest Paid | N/A | 7.55M | 2.70M | 40.00K | 30.00K | |||
| Other non cash items | -2.02M | 21.42M | 19.42M | 19.50M | 14.61M | |||
| OPERATING CASH FLOW | -84.08M | -155.01M | -135.34M | -82.15M | -66.35M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -20.00K | -140.00K | -450.00K | -320.00K | |||
| INVESTING CASH FLOW | N/A | -20.00K | -140.00K | -450.00K | -320.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 98.60M | N/A | N/A | |||
| Stock Issued/Repurchased | 35.06M | 27.54M | 280.00K | 102.45M | 247.36M | |||
| Other Financing Activity | -551.00K | -1.02M | -2.65M | N/A | N/A | |||
| FINANCING CASH FLOW | 34.51M | 26.52M | 96.24M | 102.45M | 247.36M | |||
| CHANGE IN CASH | -49.58M | -128.50M | -39.24M | 19.85M | 180.69M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -84.08M | -155.01M | -135.34M | -82.15M | -66.35M | |||
| Capital Expenditure | N/A | -20.00K | -140.00K | -450.00K | -320.00K | |||
| FREE CASH FLOW | -84.08M | -155.03M | -135.48M | -82.60M | -66.67M | |||
All data in USD